Iloperidone: Preclinical Profile and Early Clinical Evaluation
Open Access
- 1 June 1997
- journal article
- Published by Wiley in CNS Drug Reviews
- Vol. 3 (2) , 120-147
- https://doi.org/10.1111/j.1527-3458.1997.tb00320.x
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Medical Complications of New Antipsychotic DrugsSchizophrenia Bulletin, 1996
- Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptorsNature, 1995
- 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-Benzisoxazoles as D2/5-HT2 Antagonists with Potential Atypical Antipsychotic Activity: Antipsychotic Profile of Iloperidone (HP 873)Journal of Medicinal Chemistry, 1995
- Biochemical Findings of Negative Symptoms in Schizophrenia and Their Putative Relevance to Pharmacological TreatmentNeuropsychobiology, 1994
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical dosesPharmacology Biochemistry and Behavior, 1981
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamenJournal of Pharmacy and Pharmacology, 1977
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- Avoidance Conditioning with Brief Shock and No Exteroceptive Warning SignalScience, 1953